SC

Samit Chowdhury

Active Director Director DIN 09397218
DIN 09397218 First appointment Nov 2021 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Samit Chowdhury

Data last updated:

Samit Chowdhury is a Director at S. R. A. Pharmaticeucal And Medicine Private Limited (since 2021). The company operates in Food And Beverages.

DIN 09397218
Primary Designation Director
Industry Food And Beverages
First Appointment 12 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Nov 20212021Active

Directorship timeline

Open interactive timeline →
S. R. A. Pharmaticeucal And Medicine Private Limited
Premium access

Shareholding and investment profile for Samit Chowdhury

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samit Chowdhury

Samit Chowdhury currently holds 1 directorship: S. R. A. Pharmaticeucal And Medicine Private Limited (Director, since 12 Nov 2021).

Samit Chowdhury was first appointed on 12 Nov 2021 as Director at S. R. A. Pharmaticeucal And Medicine Private Limited.

The current boards of Samit Chowdhury's companies include Arpita Das Kafi (S. R. A. Pharmaticeucal And Medicine Private Limited), Mahammad Abdullahil Kafi (S. R. A. Pharmaticeucal And Medicine Private Limited), Rupali Chowdhury (S. R. A. Pharmaticeucal And Medicine Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available